Provention Bio (PRVB) Short Interest Ratio & Short Volume → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free PRVB Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Provention Bio Short Interest DataCurrent Short Volume5,370,000 sharesPrevious Short Volume5,880,000 sharesChange Vs. Previous Month-8.67%Dollar Volume Sold Short$130.76 millionShort Interest Ratio / Days to Cover2.3Last Record DateApril 15, 2023Outstanding Shares94,780,000 sharesPercentage of Shares Shorted5.67%Today's Trading Volume9,124,100 sharesAverage Trading Volume2,277,701 sharesToday's Volume Vs. Average401% Short Selling Provention Bio ? Sign up to receive the latest short interest report for Provention Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPRVB Short Interest Over TimePRVB Days to Cover Over TimePRVB Percentage of Float Shorted Over Time Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. Provention Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20235,370,000 shares $130.76 million -8.7%N/A2.3 $24.35 3/31/20235,880,000 shares $141.71 million +44.1%N/A2.6 $24.10 3/15/20234,080,000 shares $97.55 million -50.2%N/A2 $23.91 2/28/20238,200,000 shares $68.06 million +6.6%N/A7.3 $8.30 2/15/20237,690,000 shares $74.21 million +1.7%N/A6.1 $9.65 1/31/20237,560,000 shares $65.47 million +3.9%N/A5 $8.66 Get the Latest News and Ratings for PRVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Provention Bio and its competitors with MarketBeat's FREE daily newsletter. 1/15/20237,280,000 shares $74.98 million -1.8%N/A4.1 $10.30 12/30/20227,410,000 shares $78.32 million +19.3%N/A4.1 $10.57 12/15/20226,210,000 shares $57.75 million -13.9%N/A3.2 $9.30 11/30/20227,210,000 shares $65.18 million +20.8%N/A3.9 $9.04 11/15/20225,970,000 shares $54.09 million +13.5%N/A3.2 $9.06 10/31/20225,260,000 shares $36.50 million +51.2%N/A3.5 $6.94 10/15/20223,480,000 shares $24.05 million -0.3%N/A3 $6.91 9/30/20223,490,000 shares $15.71 million +26.9%N/A3.3 $4.50 9/15/20222,750,000 shares $14.71 million -1.8%N/A3.4 $5.35 8/31/20222,800,000 shares $12.10 million -3.8%N/A3.6 $4.32 8/15/20222,910,000 shares $16.35 million -14.7%N/A4.4 $5.62 7/31/20223,410,000 shares $13.03 million -11.2%5.9%5.7 $3.82 7/15/20223,840,000 shares $17.28 million +0.8%7.3%6.4 $4.50 6/30/20223,810,000 shares $15.24 million -8.0%7.2%6.4 $4.00 6/15/20224,140,000 shares $15.77 million +3.2%7.8%7.2 $3.81 5/31/20224,010,000 shares $16.52 million +9.9%7.6%7.3 $4.12 5/15/20223,650,000 shares $15.07 million +2.8%6.9%6.4 $4.13 4/30/20223,550,000 shares $15.94 million No Change6.7%6 $4.49 4/15/20223,550,000 shares $22.97 million -0.8%6.7%3.6 $6.47 3/31/20223,580,000 shares $26.21 million -21.7%6.7%3.6 $7.32 3/15/20224,570,000 shares $31.90 million -2.1%8.6%4.6 $6.98 2/28/20224,670,000 shares $29.28 million +0.9%8.8%4.7 $6.27 2/15/20224,630,000 shares $30.65 million +20.3%8.7%4.5 $6.62 1/31/20223,850,000 shares $20.64 million +9.1%7.2%3.6 $5.36 1/15/20223,530,000 shares $16.77 million +6.7%6.6%5.6 $4.75 12/31/20213,310,000 shares $18.60 million +4.4%6.2%5.6 $5.62 12/15/20213,170,000 shares $19.24 million +10.1%6.0%5.6 $6.07 11/30/20212,880,000 shares $19.87 million +18.5%5.4%5.2 $6.90 11/15/20212,430,000 shares $14.90 million -3.2%4.6%4.5 $6.13 10/29/20212,510,000 shares $15.71 million -4.2%5.0%5.5 $6.26 10/15/20212,620,000 shares $16.24 million -5.8%5.2%5.2 $6.20 9/30/20212,780,000 shares $17.79 million -8.3%5.5%4.5 $6.40 9/15/20213,030,000 shares $19.42 million -4.7%6.0%2.9 $6.41 8/31/20213,180,000 shares $21.34 million -12.9%6.3%2.7 $6.71Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. PRVB Short Interest - Frequently Asked Questions What is Provention Bio's current short interest? Short interest is the volume of Provention Bio shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 5,370,000 shares of PRVB short. Learn More on Provention Bio's current short interest. What is a good short interest ratio for Provention Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PRVB shares currently have a short interest ratio of 2.0. Learn More on Provention Bio's short interest ratio. Is Provention Bio's short interest increasing or decreasing? Provention Bio saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 5,370,000 shares, a drop of 8.7% from the previous total of 5,880,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Provention Bio's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Provention Bio: Corcept Therapeutics Incorporated (23.68%), Merus (5.61%), Rhythm Pharmaceuticals, Inc. (16.96%), Arvinas, Inc. (13.09%), TG Therapeutics, Inc. (25.55%), Dyne Therapeutics, Inc. (10.47%), Indivior PLC (0.15%), Janux Therapeutics, Inc. (9.99%), Vera Therapeutics, Inc. (16.07%), Rocket Pharmaceuticals, Inc. (12.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.69 billion), Occidental Petroleum Co. ($3.22 billion), Coinbase Global, Inc. ($2.54 billion), T. Rowe Price Group, Inc. ($2.33 billion), Paramount Global ($2.10 billion), Verisk Analytics, Inc. ($2.03 billion), Etsy, Inc. ($1.67 billion), Old Dominion Freight Line, Inc. ($1.62 billion), CarMax, Inc. ($1.60 billion), and Extra Space Storage Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Provention Bio stock? Short selling PRVB is an investing strategy that aims to generate trading profit from Provention Bio as its price is falling. PRVB shares are trading up $0.75 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Provention Bio? A short squeeze for Provention Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PRVB, which in turn drives the price of the stock up even further. How often is Provention Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRVB, twice per month. The most recent reporting period available is April, 15 2023. More Short Interest Resources from MarketBeat Related Companies: Corcept Therapeutics Short Interest Data Merus Short Interest Data Rhythm Pharmaceuticals Short Interest Data Arvinas Short Interest Data TG Therapeutics Short Interest Data Dyne Therapeutics Short Interest Data Indivior Short Interest Data Janux Therapeutics Short Interest Data Vera Therapeutics Short Interest Data Rocket Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRVB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals